For Immediate Release Contact firstname.lastname@example.org
February 16, 2011
TUSTIN, Calif., Feb. 16, 2011 – For physicians, the ability to streamline exams for determining a patient’s risk for cardiovascular disease is important in determining the patient’s clinical pathway. To enhance diagnostic efficiency, Toshiba America Medical Systems, Inc. has introduced Auto-IMTTM, an ultrasound software tool that can measure the thickness of the intima-media layers of the carotid artery, for evaluating an asymptomatic patient’s risk of developing cardiovascular disease. Toshiba has recently received FDA clearance for Auto-IMT, and it is now available on the AplioTM XG, Aplio MX and XarioTM XG ultrasound systems.
Toshiba’s Auto-IMT can determine the thickness of the near and far arterial walls from three segments of the carotid artery: at an optimal angle of incidence and two complementary planes. Auto-IMT traces the two complementary planes automatically and calculates the distance between them. The Auto-IMT uses the collected images following the American Society of Echocardiography’s (ASE) consensus statement for the diagnosis.
Toshiba worked with Midwest Ultrasound, a division of The Christ Hospital in Cincinnati, Ohio, to develop the software tool. Midwest Ultrasound is a nationally recognized leader in providing quality cardiac and vascular ultrasound services, and maintains a diverse client mix, from small rural and community hospitals to major urban academic centers and large physician practices in southwest Ohio. Midwest Ultrasound will be using Auto IMT on all 25 of its Toshiba Xario XG systems.
“Auto-IMT has helped us reduce the time it takes to evaluate carotid artery wall thickness from 45 minutes to less than 10 minutes, allowing us to evaluate more patients in less time,” said David Parlato, director, Clinical Operations, Midwest Ultrasound. “In addition, the ability to image and measure the artery in real time eliminates the need for interim centralized PACS storage and off-line workstation review, which enables us to provide IMT-based risk screening much more efficiently for our patients.”
“Measuring IMT at a faster pace helps identify high-risk patients before a cardiac episode occurs, which we believe leads to better patient outcomes,” said Tomo Hasegawa, director, Ultrasound Business Unit, Toshiba. “Toshiba is committed to improving patient care and providing ways to streamline processes so patients receive the highest quality care more efficiently.”
Midwest Ultrasound, Inc., a wholly owned subsidiary of The Christ Hospital in Cincinnati, Ohio, is the regional leader in Ohio, Indiana and Kentucky for providing diagnostic ultrasound services (cardiac, vascular and general) in partnerships with hospitals and large physician practices. Midwest Ultrasound’s comprehensive services include top-quality testing through state-of-the-art equipment, highly trained professional sonographers, lab accreditation, physician education, quality assurance and a focused management approach of a facility’s ultrasound department.
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, MRI and information systems. Toshiba Corp. is a worldwide leader in technology, electronic and electrical products, digital consumer products, electronic devices and components, power systems, industrial and social infrastructure systems and home appliances. Toshiba was founded in 1875 and today operates a global network of more than 742 companies with more than 204,000 employees worldwide and annual sales surpassing $68 billion. For more information, visit Toshiba’s website at www.medical.toshiba.com.